Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00384566Phase 4Withdrawn
Phase 4, randomised trial of carvedilol in heart failure (HF) (2 arms), sponsored by Alfred Health. Primary endpoints: Respiratory function, NYHA class and 4 more. Planned start Jun 2005; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00384566.